![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
501kB |
| Item Type: | Article |
|---|---|
| Title: | Do female and male patients with cervical dystonia respond differently to long-term botulinum neurotoxin therapy? |
| Creators Name: | Hefter, H., Samadzadeh, S. and Moll, M. |
| Abstract: | BACKGROUND: Idiopathic cervical dystonia (CD) affects more female than male patients. This sex-based influence on the clinical manifestation of CD may also affect outcomes after long-term BoNT therapy. METHODS: To analyze the potential differential influence of sex on the efficacy of BoNT therapy, a cross-sectional study was conducted with 135 female and 85 male patients with idiopathic cervical dystonia. Demographic and treatment-related data were extracted from patient charts. The 24-item Cervical Dystonia Questionnaire (CDQ24), patients' self-assessment of CD severity (PAS), and the TSUI score were used as outcome measures. On the day of recruitment, blood samples were collected to analyze neutralizing antibody (NAB) formation using an ELISA, with confirmation by the mouse hemidiaphragm assay (MHDA) test. RESULTS: Male patients had significantly (p < 0.02) lower mean age and age at symptom onset and received significantly (p < 0.02) higher BoNT doses per session. Female patients had significantly worse PAS and CDQ24 scores (p < 0.006), though the TSUI score showed no significant difference (p = 0.19). Despite receiving lower BoNT doses, female patients exhibited a significantly (p < 0.006) higher risk of NAB induction. CONCLUSION: This reanalysis of previously published data reveals that female and male patients in this cohort were treated and responded differently to long-term BoNT therapy, a discrepancy that remained unnoticed by their treating physicians over more than 10 years of treatment. |
| Keywords: | Cervical Dystonia, Botulinum Neurotoxin, Long-Term Outcome, Females, Males, Antibody Formation |
| Source: | Frontiers in Neurology |
| ISSN: | 1664-2295 |
| Publisher: | Frontiers Media SA |
| Volume: | 16 |
| Page Range: | 1553989 |
| Date: | 17 June 2025 |
| Official Publication: | https://doi.org/10.3389/fneur.2025.1553989 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
